81 related articles for article (PubMed ID: 25273565)
1. Expression of avian influenza haemagglutinin (H5) and chicken interleukin 2 (chIL-2) under control of the ptcB promoter in Lactococcus lactis.
Szatraj K; Szczepankowska AK; Sączyńska V; Florys K; Gromadzka B; Łepek K; Płucienniczak G; Szewczyk B; Zagórski-Ostoja W; Bardowski J
Acta Biochim Pol; 2014; 61(3):609-14. PubMed ID: 25273565
[TBL] [Abstract][Full Text] [Related]
2. Recombinant
Szczepankowska AK; Szatraj K; Sałański P; Rózga A; Górecki RK; Bardowski JK
Biomed Res Int; 2017; 2017():6747482. PubMed ID: 28321412
[TBL] [Abstract][Full Text] [Related]
3. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
[TBL] [Abstract][Full Text] [Related]
4. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
[TBL] [Abstract][Full Text] [Related]
5. The immune response of a recombinant fowlpox virus coexpressing the HA gene of the H5N1 highly pathogenic avian influenza virus and chicken interleukin 6 gene in ducks.
Qian C; Chen S; Ding P; Chai M; Xu C; Gan J; Peng D; Liu X
Vaccine; 2012 Sep; 30(44):6279-86. PubMed ID: 22902682
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
7. Recombinant haemagglutinin protein of highly pathogenic avian influenza A (H5N1) virus expressed in Pichia pastoris elicits a neutralizing antibody response in mice.
Murugan S; Ponsekaran S; Kannivel L; Mangamoori LN; Chandran D; Villuppanoor Alwar S; Chakravarty C; Lal SK
J Virol Methods; 2013 Jan; 187(1):20-5. PubMed ID: 22871671
[TBL] [Abstract][Full Text] [Related]
8. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
[TBL] [Abstract][Full Text] [Related]
9. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
[TBL] [Abstract][Full Text] [Related]
10. A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens.
Wu Q; Fang L; Wu X; Li B; Luo R; Yu Z; Jin M; Chen H; Xiao S
Mol Immunol; 2009 Jul; 46(11-12):2210-7. PubMed ID: 19446339
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity and immunological responses following oral vaccination of nanoencapsulated avian influenza virus H5 DNA vaccine with green synthesis silver nanoparticles.
Jazayeri SD; Ideris A; Zakaria Z; Shameli K; Moeini H; Omar AR
J Control Release; 2012 Jul; 161(1):116-23. PubMed ID: 22549012
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccine encoding avian influenza virus H5 and Esat-6 of Mycobacterium tuberculosis improved antibody responses against AIV in chickens.
Oveissi S; Omar AR; Yusoff K; Jahanshiri F; Hassan SS
Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):491-503. PubMed ID: 19781778
[TBL] [Abstract][Full Text] [Related]
13. Improved immune responses against avian influenza virus following oral vaccination of chickens with HA DNA vaccine using attenuated Salmonella typhimurium as carrier.
Jazayeri SD; Ideris A; Zakaria Z; Yeap SK; Omar AR
Comp Immunol Microbiol Infect Dis; 2012 Sep; 35(5):417-27. PubMed ID: 22512819
[TBL] [Abstract][Full Text] [Related]
14. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
15. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector.
Jiang Y; Yu K; Zhang H; Zhang P; Li C; Tian G; Li Y; Wang X; Ge J; Bu Z; Chen H
Antiviral Res; 2007 Sep; 75(3):234-41. PubMed ID: 17451817
[TBL] [Abstract][Full Text] [Related]
16. [Construction and immunogenicity of attenuated Salmonella typhimurium harbouring stable DNA vaccine against H5 subtype of avian influenza virus].
Tang LH; Pan ZM; Cheng NN; Jiao XA; Zhang XM
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):662-6. PubMed ID: 17944368
[TBL] [Abstract][Full Text] [Related]
17. [Construction, genetic stability and protective efficacy of recombinant fowlpox virus expressing hemagglutinin gene of H5N1 subtype avian influenza virus].
Jia L; Peng D; Zhang Y; Liu H; Liu X
Wei Sheng Wu Xue Bao; 2003 Dec; 43(6):722-7. PubMed ID: 16276892
[TBL] [Abstract][Full Text] [Related]
18. Immunoprotection against influenza H5N1 virus by oral administration of enteric-coated recombinant Lactococcus lactis mini-capsules.
Lei H; Xu Y; Chen J; Wei X; Lam DM
Virology; 2010 Nov; 407(2):319-24. PubMed ID: 20850860
[TBL] [Abstract][Full Text] [Related]
19. Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.
Niqueux E; Guionie O; Amelot M; Jestin V
Vaccine; 2013 Aug; 31(38):4121-8. PubMed ID: 23845804
[TBL] [Abstract][Full Text] [Related]
20. Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.
Rauw F; Palya V; Van Borm S; Welby S; Tatar-Kis T; Gardin Y; Dorsey KM; Aly MM; Hassan MK; Soliman MA; Lambrecht B; van den Berg T
Vaccine; 2011 Mar; 29(14):2590-600. PubMed ID: 21292007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
